3 Questions For A Patent Litigator Turned Legal Recruiter (Part II)
The patent litigation market is ever-changing.
The patent litigation market is ever-changing.
Khurram Naik was a major contributor to one of the IP success stories of 2025.
Put away the guesswork—Lexis® Verdict & Settlement Analyzer helps legal professionals assess case potential with confidence by using data-driven insights from the industry’s largest collection of verdicts and settlements.
Despite economic challenges, certain law practice areas are observing renewed hiring activity as the economy progresses in 2023.
We can expect, however, that other unsuccessful IPR litigants will continue to push for a narrower estoppel application in terms of their validity defenses at trial.
When a SCOTUS decision is rendered on a sexy patent topic, there is a good chance that the reaction will be both more intense and accelerated.
Whether the rocket docket/NHK-Fintiv interplay resulting in discretionary denial survives additional PTAB scrutiny is clearly up for debate at this point, and further developments beg a watchful eye.
Legal teams ask a practical question. If large language models are so capable, why does legal AI still depend on curated content, and why does surfacing that content matter so much?
A relatively recent development in modern patent litigation has quickly become a hot-button issue.
The complex and challenging world of IP law presents a number of problems to be solved -- and litigation financing can help.
The data and experience of women don't look good.
Large patent cases present both an opportunity and a challenge for everyone involved -- including the courts.
From a court’s perspective, settlement is as good a case management tool as it gets.
Proper preservation practice is an important component of a winning patent litigation approach.
IP columnist Gaston Kroub interviews a prevailing party in a patent dispute.
A pending Supreme Court case could have significant implications for patent litigation.
This technology could prove to be the greatest biotech advance in recent history.